Owned and operated by a cf veteran 
Independent analytical report
Retatrutide 10 mg — Task 203801
Review the report details, original PDF and Janoshik verification record.
Report summary
- Compound
- Retatrutide
- Strength
- 10 mg
- Reported purity
- 98.616%
- Tested quantity
- 11.01 mg
- Report date
- July 25, 2026
- Janoshik task ID
- #203801
Janoshik received this Retatrutide sample on 17 July 2026 and completed analysis on 25 July. The laboratory reported 11.01 mg of Retatrutide at 98.616 percent purity.
The test applied was a common GLP-1 blind panel, screening simultaneously for Semaglutide, Tirzepatide and Retatrutide. Because the analyst is not told which compound to expect, the panel confirms identity as well as quantity. This is the most recent of three analytical records held for the 10 mg presentation; the earlier two remain published below it as report history.
This certificate describes the submitted sample identified in the report. It does not establish clinical safety, efficacy, suitability for human or veterinary use, or the specifications of future inventory.